These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7841858)

  • 21. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):137-141. PubMed ID: 30133420
    [No Abstract]   [Full Text] [Related]  

  • 23. Expanded table: Some drugs for management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone.
    Wright C; Bigelow GE; Stitzer ML; Liebson IA
    Drug Alcohol Depend; 1991 Mar; 27(2):139-48. PubMed ID: 1647293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs approved for opiate dependence.
    FDA Consum; 2003; 37(1):6. PubMed ID: 12625293
    [No Abstract]   [Full Text] [Related]  

  • 26. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N; Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1996 Dec; 43(1-2):87-91. PubMed ID: 8957147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone-induced withdrawal in patients with buprenorphine dependence.
    Nigam AK; Srivastava RP; Saxena S; Chavan BS; Sundaram KR
    Addiction; 1994 Mar; 89(3):317-20. PubMed ID: 8173501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mr R: a case study of withdrawal.
    Dennison SJ
    Behav Med; 1992; 18(3):139-40. PubMed ID: 1330103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating opiate addiction, Part I. Detoxification and maintenance.
    Harv Ment Health Lett; 2004 Dec; 21(6):4-6. PubMed ID: 15717347
    [No Abstract]   [Full Text] [Related]  

  • 32. Methadone combined with clonidine versus clonidine alone in opiate detoxification.
    Wilson RS; DiGeorge WS
    J Subst Abuse Treat; 1993; 10(6):529-35. PubMed ID: 8308937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
    Olmstead MC; Burns LH
    Psychopharmacology (Berl); 2005 Sep; 181(3):576-81. PubMed ID: 16010543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opiate withdrawal syndrome: acute and protracted aspects.
    Jasinski DR
    Ann N Y Acad Sci; 1981; 362():183-6. PubMed ID: 6942707
    [No Abstract]   [Full Text] [Related]  

  • 35. [Opiate withdrawal in anesthesia (forced narcotic withdrawal, "turbo withdrawal") in narcotic dependence. Changes in withdrawal treatment--wishes and reality].
    Dettling M; Tretter F
    Nervenarzt; 1996 Sep; 67(9):805-10. PubMed ID: 8992381
    [No Abstract]   [Full Text] [Related]  

  • 36. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged-release naloxone can cause systemic opioid withdrawal.
    Wilcock A
    Eur J Pain; 2009 Oct; 13(9):1001; author reply 1002-3. PubMed ID: 19615925
    [No Abstract]   [Full Text] [Related]  

  • 38. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
    Caillé S; Espejo EF; Koob GF; Stinus L
    Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial methadone dose in treating opiate addiction.
    Wang RI; Kochar C; Hasegawa AT; Roh BL
    Int J Addict; 1982 Feb; 17(2):357-63. PubMed ID: 7076369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
    Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
    Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.